AFT Pharmaceuticals considers IPO, listing on NZX and ASX as it eyes international sales

Sophie Boot
Tue, 17 Nov 2015

By Sophie Boot Nov. 17 (BusinessDesk) - AFT Pharmaceuticals, the Auckland-based pharmaceutical company, is considering a $49 million initial public offering along with listing on the NZX and ASX. The proposed offer involves a primary raise of $45 million, and a $4 million selldown by the Atkinson Family Trust, which owns 87 percent of the company. AFT, which was founded in 1997, made a loss of $12.9 million for the year ended March 31, on revenue of $56.2 million. The company has achieved a compound annual growth rate in operating reve...
MARKET CLOSE: NZ shares rise as optimism over covid drug buoys Asia
Dan Brunskill | Mon, 13 Jul 2020

New Zealand shares joined a rally across Asia, as upbeat investor sentiment spilled over from Wall Street's close on Friday on optimism over a late-stage trial for a hopeful covid-19 treatment.  Th...

Law & Regulation
SFO probes Labour Party on donations
Victoria Young | Mon, 13 Jul 2020

The Serious Fraud Office has confirmed a fifth investigation into electoral funding, stating today it is looking into donations to the Labour Party.The agency said the probe relates to donations made...

NZ dollar little changed as global shares defy worsening covid news
Jenny Ruth | Mon, 13 Jul 2020

The New Zealand dollar was little changed as traders awaited further trend-setting information and as rising share markets were offset by Florida reporting a US record for new covid infections. The...

The role of private equity in the wake of COVID-19

As local covid-19 restrictions ease, a new business cycle is beginning in New Zealand.